Cancer Vaccines for Hormone/Growth Factor Immune Deprivation:A Feasible Approach for Cancer Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|7|3|229-241

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.3, 2007-05, pp. : 229-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel plus estramustine and 15-month androgen deprivation therapy is feasible for the treatment of early prostate cancer relapse

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Cancer vaccine treatment feasible for paediatric solid tumours

By  

Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in the Treatment of Colorectal Cancer: State of the Art

By Diasio Robert B.   Fourie Jeanne  

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1441-1463

Adis International

Access to resources Recommend Favorite

Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer

By Yuen John SP   Macaulay Valentine M  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 589-603

Informa Healthcare

Access to resources Recommend Favorite

Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2899-2911

Bentham Science Publishers

Access to resources Recommend Favorite